#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour of the lung Thalassaemia beta Myxofibrosarcoma Cryoglobulinaemia Hypergammaglobulinaemia benign monoclonal Factor IX deficiency Systemic candida Haemophilia B without inhibitors Myelin oligodendrocyte glycoprotein antibody-associated disease Chronic lymphocytic leukaemia refractory Paroxysmal nocturnal haemoglobinuria Adrenogenital syndrome Vascular malformation Microvillous inclusion disease Duchenne muscular dystrophy More trials…

    Learn about Rare Diseases

    Phenylketonuria – Treatment Propionic acidaemia Hereditary angioedema – Diagnostics Ewing’s sarcoma metastatic – Diagnostics Adrenocortical carcinoma Pulmonary sarcoidosis – Life with Disease Myelodysplastic syndrome with excess blasts – Diagnostics CADASIL – Treatment Cholangitis sclerosing – Treatment Marginal zone lymphoma refractory More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Spartalizumab Procarbazine Alemtuzumab GSKVX000000048110 L-Histidine Nizaracianine Triflutate TRV045 Camphor Oxcarbazepine Dazukibart Soya Oil MB-HUCART19.1 VOROLANIB Sasanlimab Oxymetazoline Hydrochloride Vidutolimod Gen1046 Secale Cereale Nimorazole Lorazepam More therapies…

    Learn about Your Condition

    Colorectal cancer metastatic Synovial sarcoma Rectal cancer stage II Vascular calcification Rabies Hypotension Muscle spasticity Alcohol abuse Pancreatic fistula Oral lichen planus Inguinal hernia Breast conserving surgery Genital herpes simplex Myocarditis Cervix carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Inflammatory bowel disease

  • Modafinil for Severe Fatigue in Patients with Quiescent Inflammatory Bowel Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    Investigated Drugs:
    • Modafinil
    • Placebo
    The Netherlands

  • Study Using Fluorescent Adalimumab and Risankizumab to See How These Drugs Work in Patients with Inflammatory Bowel Disease

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Risankizumab
    • Adalimumab
    The Netherlands

  • Study on How Gut Bacteria Affect Energy Use in Cells for Healthy Adults and Patients with Inflammatory Bowel Disease Using Amphotericin B, Vancomycin, and Gentamicin Sulfate

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Amphotericin B
    • Vancomycin
    • Gentamicin Sulfate
    France

  • Study on Pain Relief Using Lidocaine and Sodium Chloride in Patients with Chronic Inflammatory Bowel Disease and Abdominal Pain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Sodium Chloride
    Belgium

  • Title: Study of vedolizumab dose adjustment guided by drug level monitoring in patients with inflammatory bowel disease in remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Vedolizumab
    The Netherlands

  • Study on the Safety of Faster Infusions for Cancer Patients Using Trastuzumab, Bevacizumab, and Atezolizumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    • Rheumatic disorder
    Investigated Drugs:
    • Ipilimumab
    • Panitumumab
    • Pertuzumab
    The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!